Amalgamated Bank’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12K Hold
9,441
﹤0.01% 2370
2025
Q1
$11K Buy
9,441
+1,213
+15% +$1.41K ﹤0.01% 2334
2024
Q4
$15K Hold
8,228
﹤0.01% 2250
2024
Q3
$14K Hold
8,228
﹤0.01% 2294
2024
Q2
$11K Hold
8,228
﹤0.01% 2399
2024
Q1
$31K Sell
8,228
-20,996
-72% -$79.1K ﹤0.01% 1997
2023
Q4
$287K Sell
29,224
-2,449
-8% -$24.1K ﹤0.01% 1671
2023
Q3
$264K Hold
31,673
﹤0.01% 1684
2023
Q2
$421K Buy
31,673
+6,522
+26% +$86.7K ﹤0.01% 1519
2023
Q1
$291K Sell
25,151
-4,794
-16% -$55.5K ﹤0.01% 1654
2022
Q4
$245K Buy
29,945
+1,057
+4% +$8.65K ﹤0.01% 1780
2022
Q3
$168K Buy
28,888
+281
+1% +$1.63K ﹤0.01% 1914
2022
Q2
$126K Buy
28,607
+1,374
+5% +$6.05K ﹤0.01% 2080
2022
Q1
$248K Sell
27,233
-2,096
-7% -$19.1K ﹤0.01% 1854
2021
Q4
$600K Sell
29,329
-291
-1% -$5.95K ﹤0.01% 1495
2021
Q3
$757K Sell
29,620
-1,995
-6% -$51K 0.01% 1387
2021
Q2
$1.11M Buy
31,615
+7,047
+29% +$247K 0.01% 1240
2021
Q1
$818K Sell
24,568
-1,470
-6% -$48.9K 0.03% 695
2020
Q4
$675K Buy
26,038
+1,714
+7% +$44.4K 0.03% 787
2020
Q3
$240K Buy
24,324
+2,482
+11% +$24.5K 0.01% 1231
2020
Q2
$75K Sell
21,842
-3,385
-13% -$11.6K ﹤0.01% 1429
2020
Q1
$77K Sell
25,227
-543
-2% -$1.66K ﹤0.01% 1525
2019
Q4
$132K Buy
25,770
+807
+3% +$4.13K ﹤0.01% 1702
2019
Q3
$129K Sell
24,963
-155
-0.6% -$801 ﹤0.01% 1623
2019
Q2
$152K Buy
25,118
+4,543
+22% +$27.5K ﹤0.01% 1637
2019
Q1
$149K Buy
20,575
+717
+4% +$5.19K ﹤0.01% 1559
2018
Q4
$147K Buy
+19,858
New +$147K ﹤0.01% 1467
2018
Q3
Sell
-18,738
Closed -$67K 1568
2018
Q2
$67K Buy
18,738
+3,020
+19% +$10.8K ﹤0.01% 1680
2018
Q1
$32K Buy
15,718
+1,565
+11% +$3.19K ﹤0.01% 1592
2017
Q4
$37K Buy
14,153
+1,029
+8% +$2.69K ﹤0.01% 1632
2017
Q3
$69K Buy
13,124
+2,367
+22% +$12.4K ﹤0.01% 1531
2017
Q2
$38K Buy
+10,757
New +$38K ﹤0.01% 1555